Drug Treatment Policy in the Criminal Justice System: A Scoping Literature Review

[1]  R. Devellis,et al.  Opt-out HIV testing in prison: informed and voluntary? , 2015, AIDS care.

[2]  Zunyou Wu,et al.  Needle and syringe exchange programmes and prevalence of HIV infection among intravenous drug users in China. , 2015, Addiction.

[3]  C. Golin,et al.  Multilevel challenges to engagement in HIV care after prison release: a theory-informed qualitative study comparing prisoners’ perspectives before and after community reentry , 2014, BMC Public Health.

[4]  Catherine Duplessy,et al.  Long-term survey of a syringe-dispensing machine needle exchange program: answering public concerns , 2014, Harm Reduction Journal.

[5]  M. Hellard,et al.  Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. , 2014, International journal of epidemiology.

[6]  M. Golichenko,et al.  Atmospheric pressure: Russian drug policy as a driver for violations of the UN Convention against Torture and the International Covenant on Economic, Social and Cultural Rights. , 2013, Health and human rights.

[7]  Fiona Clark.  Global drug policy fuels hepatitis C epidemic, report warns , 2013, The Lancet.

[8]  M. Anglin,et al.  Offender diversion into substance use disorder treatment: the economic impact of California's proposition 36. , 2013, American journal of public health.

[9]  J. Rich,et al.  Forced withdrawal from methadone maintenance therapy in criminal justice settings: a critical treatment barrier in the United States. , 2013, Journal of substance abuse treatment.

[10]  A. Ritter,et al.  Public opinion and drug policy in Australia: engaging the 'affected community'. , 2013, Drug and alcohol review.

[11]  Teemu Kaskela,et al.  Prison-based drug treatment in Finland: History, shifts in policy making and current status , 2012 .

[12]  K. O’grady,et al.  A Randomized Clinical Trial of Methadone Maintenance for Prisoners: Prediction of Treatment Entry and Completion in Prison , 2012, Journal of offender rehabilitation.

[13]  D. Rastegar,et al.  Criminal charges prior to and after initiation of office-based buprenorphine treatment , 2012, Substance Abuse Treatment, Prevention, and Policy.

[14]  M. Anglin,et al.  Band-Aids and Bullhorns , 2012 .

[15]  Vic W. Bumphus,et al.  Exploring General and Specific Attitudes Toward Drug Policies Among College Students , 2012 .

[16]  Dustin Albert,et al.  Pathways to treatment retention for individuals legally coerced to substance use treatment: the interaction of hope and treatment motivation. , 2011, Drug and alcohol dependence.

[17]  M. Kals,et al.  Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia , 2011, BMC public health.

[18]  N. Mckeganey.  From harm reduction to drug user abstinence: a journey in drug treatment policy , 2011 .

[19]  A. Stevens.  Drug policy, harm and human rights: a rationalist approach. , 2011, The International journal on drug policy.

[20]  R. Brooner,et al.  Benefits of concurrent syringe exchange and substance abuse treatment participation. , 2011, Journal of substance abuse treatment.

[21]  A. Ritter.  Conceptualising 'balance' in national drug policy. , 2010, Drug and alcohol review.

[22]  H. Arksey,et al.  Scoping studies: towards a methodological framework , 2005 .